Goldenwell Biotech, Inc. (GWLL): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

99.00M
As of 2025-12-31
99.00M
As of 2026-06-30
0.0%
3-year compound annual growth
2019-12-31: 80.00M2020-12-31: 91.50M2021-12-31: 91.50M2022-12-31: 99.00M2023-12-31: 99.00M2024-12-31: 99.00M2025-12-31: 99.00M99.00M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3199.00M0.0%2026-07-01, Balance as of period end
2024-12-3199.00M0.0%2026-07-01, Balance as of period end
2023-12-3199.00M0.0%2025-05-15, Balance as of period end
2022-12-3199.00M+8.2%2024-04-12, Balance as of period end
2021-12-3191.50Mn/c2023-04-13, Balance as of period end
2020-12-3191.50M+14.4%2023-02-06, Balance as of period end
2019-12-3180.00Mn/a2021-07-23, Balance as of period end